CannaMD

NOVEMBER 6, 2019

In the fall of 2018, scientists at the San Francisco Veterans Affairs Medical Center released findings from a survey on the subject of marijuana versus opioids. billion opioid prescriptions written between 2011 and 2018. Using Cannabis to Quit Opioids. percent, respectively. million to 11.4 million to 11.4

Marijuana 87

Marijuana Patients Clinical Trials Data 87

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

AUGUST 31, 2020

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

The Joint Blog

APRIL 17, 2020

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. In 2018, ProCon.org has estimated well over 3.5M Americans have some kind of medical marijuana card or prescription.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

SEPTEMBER 24, 2019

Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. The use of ones containing THC was legalised across the UK in November 2018. In June 2018 GW, along with its U.S.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Joint Blog

JULY 25, 2020

In the United States, the passage of the 2018 Farm Bill, which de-scheduled hemp plants from the “controlled substance” list, broke the glass ceiling for the CBD industry. In short, it won’t get you high. Several countries across the globe have legalized the use of CBD for industrial applications over the last couple of years.

CBD 33

CBD Clinical Trials Safety Media 33

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132

Terpenes Strains THC Treatment 132

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

NOVEMBER 29, 2021

ATAI Life Sciences AG (NASDAQ: ATAI), the innovative mental health platform company I have started in 2018 and which is committed to unlocking the compelling potential of psychedelics, has announced this morning that it has bought an additional stake in COMPASS Pathways (NASDAQ: CMPS), bringing atai’s ownership in Compass beyond 20%.

Treatment 52

Treatment Clinical Trials Data Patients 52

Cannabis Law Report

NOVEMBER 12, 2021

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018). OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022. Dr John Lucas (CEO).

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

The Cannigma

MARCH 25, 2021

When the law changed in the UK in 2018, I was humbled by the efforts of those who suffer on a daily basis to achieve legal access to medicinal cannabis. The lively discussion highlighted how effective cannabis can be for managing not only pain , but also the often accompanying conditions of anxiety , low mood , and poor sleep.

Patients 145

Patients Clinical Trials Medicine Events 145

Cannabis Law Report

JANUARY 3, 2022

We were able to rapidly incorporate the FDA’s feedback into the design of the current Phase 2 trial to make the data generated in Europe as relevant as possible for a potential future NDA submission. in 2018, and we believe ANEB-001 holds potential to reverse symptoms safely and rapidly.”. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

The opening of London’s first such clinic follows the opening of Britain’s first medical cannabis clinic in Greater Manchester earlier in the year. Access is clearly in demand from Londoners as there is already a waiting list of 150 patients at the London clinic ahead of its opening.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents.

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Cannabis Law Report

MARCH 29, 2020

o Technology powered research: Virtual clinical trials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

SMPL

MAY 26, 2020

Cannabis that is high in CBD but extremely low in THC was made legal at the end of 2018. In the fall of 2010, a Project CBD website was set up where anyone could look through studies organized by disease or condition. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

AUGUST 30, 2019

The US Department of Agriculture (USDA) has released new data indicating a substantial increase in the growth of US hemp production. Since the passage of the 2018 Farm Bill, industrial hemp production has increased by 368 percent among US farmers as demand for CBP products has drastically risen. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Green Relief

MAY 13, 2018

LEE ON MAY 02, 2018. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. But the U.S. BY MARTIN A. CBD for CTE.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

LEE ON MAY 02, 2018. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. But the U.S. BY MARTIN A. CBD for CTE.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

The Joint Blog

AUGUST 27, 2020

According to NORML, their findings are consistent with a pair of prior studies – one from 2018 and one from earlier this year – similarly reporting reduced rates of hospitalization among SCD patients who initiate cannabis therapy. Furthermore, we sought to identify clinical characteristics of patients who would request this intervention.

Patients 49

Patients Clinical Trials Data Therapy 49

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. They aren’t geared towards treating the condition specifically, and rather focus on reducing side-effects from the disorder like anxiety and insomnia. 60% of children afflicted with anxiety had improvements in their condition.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Dr Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. IMAJ, FEBRUARY 2017. Fabricio A.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40